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Abstract
Objective:  Leukemias  comprise  the  most  common  group  of  cancers  in  children  and  adolescents.
Studies conducted  in  other  countries  and  Brazil  have  observed  a  decrease  in  their  mortality.This
study  aimed  to  evaluate  the  trend  of  mortality  from  leukemia  in  children  under  19  years  of  age
in  Brazil,  from  1980  to  2010.
Methods: This  was  an  ecological  study,  using  retrospective  time  series  data  from  the  Mortality
Information System,  from  1980  to  2010.  Calculations  of  mortality  rates  were  performed,  includ-
ing  gross,  gender-speciﬁc,  and  age-based.  For  trend  analysis,  linear  and  semi-log  regression
models  were  used.  The  signiﬁcance  level  was  5%.
Results:  Mortality  rates  for  lymphoid  and  myeloid  leukemias  presented  a  growth  trend,  with  the
exception  of  lymphoid  leukemia  among  children  under  4  years  of  age  (percentage  decrease:
1.21% annually),  while  in  the  sub-group  ‘‘Other  types  of  leukemia’’,  a  downward  trend  was
observed.  Overall,  mortality  from  leukemia  tended  to  increase  for  boys  and  girls,  especially
in the  age  groups  10-14  years  (annual  percentage  increase  of  1.23%  for  males  and  1.28%  for
females)  and  15-19  years  (annual  percentage  increase  of  1.40%  for  males  and  1.62%  for  females).
Conclusions:  The  results  for  leukemia  generally  corroborate  the  results  of  other  similar  studies.
A detailed  analysis  by  subgroup  of  leukemia,  age,  and  gender  revealed  no  trends  shown  in  other
studies,  thus  indicating  special  requirements  for  each  variable  in  the  analysis.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Análise  da  tendência  da  mortalidade  por  leucemias  infantojuvenis  no  Brasil,  de  1980
até  2010
Resumo
Objetivo:  As  leucemias  compreendem  o  grupo  mais  frequente  de  neoplasias  em  crianc¸as  e
adolescentes. Estudos  conduzidos  em  outros  países  e  no  Brasil  evidenciam,  diminuic¸ão  de
sua  mortalidade  e  aumento  da  sobrevida.  O  objetivo  do  estudo  é  conhecer  a  tendência  de
mortalidade  por  leucemia  em  menores  de  19  anos  de  idade  no  Brasil  de  1980  a  2010.
Métodos: Trata-se  de  estudo  ecológico,  retrospectivo  de  série  temporal  com  dados  extraídos  do
Sistema  de  Informac¸ão  sobre  Mortalidade,  no  período  de  1980  a  2010.  Realizados  cálculos  das
taxas  de  mortalidade  brutas  e  especíﬁcas  por  sexo  e  faixa  etária.  Para  a  análise  de  tendência
utilizou-se modelos  de  regressão  semilogarítmicos  e  lineares.  Adotado  nível  de  signiﬁcância  de
5%.
Resultados:  As  taxas  de  mortalidade  por  leucemias  linfoides  e  mieloides  apresentam  tendên-
cia de  crescimento  com  excec¸ão  das  leucemias  linfoides  entre  meninos  menores  de  4  anos
de  idade  (queda  percentual  1,21%  ao  ano),  enquanto  no  subgrupo  denominado  ‘‘Outros  tipos
de  leucemias’’  observa-se  tendência  de  queda.  De  forma  global,  a  mortalidade  por  leucemias
tende  a  aumentar  para  meninos  e  meninas,  principalmente  nas  faixas  etárias  de  10  a  14  anos
(aumento  percentual  anual  de  1,23%  para  meninos  e  1,28%  para  meninas)  e  15  a  19  anos
(aumento  percentual  anual  de  1,40%  para  meninos  e  1,62%  para  meninas).
Conclusões: Os  resultados  para  leucemias  de  forma  geral  corroboram  com  resultados  de  outros
estudos similares.  A  análise  minuciosa  por  subgrupo  de  leucemia,  faixa  etária  e  sexo  revelou
tendências  não  mostradas  em  outros  estudos,  indicando  assim  necessidades  especiais  na  análise
de  cada  variável.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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eoplasms  have  become  important  in  the  epidemiological
cenario, as  they  represent  one  of  the  leading  causes  of
eath of  in  the  1  to  19  years  age  group  in  Brazil,  second  only
o external  causes,  in  2010,  despite  the  rarity  of  childhood
ancer when  compared  to  adults.1
In  children,  tumors  are  usually  categorized  into  12
pecialty groups,  according  to  the  Third  Edition  of  the
nternational Classiﬁcation  of  Childhood  Cancer  (ICCC).
eukemias constitute  Group  I,  which  comprises  the
ubgroups: acute  lymphocytic  leukemia;  acute  myeloid
eukemia; and  chronic  myeloproliferative  disorders,  includ-
ng chronic  myeloid  leukemia  and  unspeciﬁc  or  combined
ypes. Chronic  lymphocytic  leukemia  is  extremely  rare  in
hildren and  was  therefore  included  in  the  subgroup  of  acute
ymphocytic leukemia,  the  predominant  type  of  leukemia
n children,  without  affecting  the  incidence  rates  in  this
ubgroup.2
Acute  lymphoblastic  leukemia  represents  the  majority  of
ases among  the  diagnostic  groups  of  lymphocytic  leukemias
99%), so  that  the  diagnosis  group  of  ICCC  becomes  syn-
nymous with  acute  lymphocytic  leukemia.  Likewise,  acute
onlymphocytic leukemias  are  referred  to  as  acute  myeloid
eukemia (representing  69%)  and  chronic  myeloid  leukemia,
ith 6-7%  representation  in  its  group.3Leukemias  have  the  highest  incidence  rates  among  child-
ood tumors  in  Brazil  and  worldwide.  In  a  study  conducted
n the  United  States,  of  all  neoplasms,  leukemias  showed
 frequency  of  26.3%.  In  Brazil,  they  were  also  the  most
s
l
ﬁrevalent  in  20  population-based  cancer  registries,  with  a
edian percentage  of  29%,  with  the  highest  incidence  occur-
ing in  the  age  group  1-4  years,  with  a  median  percentage
f 31.6%.  Leukemia  was  the  leading  cause  of  death  among
ancers in  children  and  adolescents  (1-18  years)  from  2001
o 2005  in  Brazil,  with  1,897  deaths  in  females  and  2,539
eaths in  males.4
The  present  study  aimed  to  assess  the  trend  of  mortality
rom childhood  leukemia  in  Brazil  from  1980  to  2010.
ethods
his  is  an  ecological,  retrospective,  time-series  study  based
n secondary  data.  The  analysis  included  cases  of  death  due
o leukemia  in  children  up  to  19  years  of  age  (inclusive),
hich occurred  in  Brazil  and  were  recorded  in  the  Mortal-
ty Information  System  (SIM)  in  the  period  of  1980-2010.
ata were  obtained  from  the  website  of  the  Department
f Informatics  of  the  Uniﬁed  Health  System  (DATASUS)1 of
he Ministry  of  Health.
The  categorization  used  was  based  on  the  International
lassiﬁcation of  Diseases,5 ninth  and  tenth  revisions,  ICD-
 (used  from  1980  to  1995)  and  ICD-10  (used  from  1996
o 2010),  as  they  were  the  classiﬁcations  used  during  the
tudied period.The study  considered  deaths  from  leukemia  those  clas-
iﬁed by  codes  204  (lymphocytic  leukemia),  205  (myeloid
eukemia), 206  (monocytic  leukemia),  207  (other  speci-
ed leukemias),  208  (leukemia  of  unspeciﬁed  cell  type)  in
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ICD-9.  Then,  the  codes  206,  207,  208  were  grouped  in  a
single stratum  called  ‘‘other  types  of  leukemias.’’  In  the
years after  1995,  the  ICD-10  was  used  with  the  codes  C91
(lymphoid leukemia),  C92  (myeloid  leukemia),  C93  (mono-
cytic leukemia),  C94  (other  leukemias  of  speciﬁc  cell  type),
C95 (leukemia  of  unspeciﬁed  cell  type),  grouping  codes
C93, C94,  C95  in  a  single  stratum  called  ‘‘other  types  of
leukemia.’’
Patients were  categorized  into  age  groups  with  a  range
of 4  years,  as  recommended  by  the  International  Agency
for Research  on  Cancer  (IARC).  Therefore  the  following  age
groups were  used:  0-4;  5-9;  10-14;  and  15-19  years.6 The
ﬁrst three  groups  correspond  to  children;  the  last,  to  adoles-
cents. The  female  and  male  genders  were  analyzed  together
and separately.
Mortality rates  from  leukemia  per  million  children  and
adolescents per  year  in  Brazil  were  calculated.  The  follow-
ing formula  was  used  to  calculate  this  coefﬁcient  in  the
selected period:  number  of  deaths  from  leukemia  by  age
group, divided  by  the  population  of  children  and  adoles-
cents, multiplied  by  1,000,000.  The  speciﬁc  mortality  rate
for each  gender  and  leukemia  subgroup  was  also  calculated
separately.
The direct  standardization  method  was  used  so  that  the
mortality rate  would  not  be  inﬂuenced  by  the  age  structure
of the  population,  allowing  for  the  comparison  with  other
populations.7
The  standard  population  used  in  this  study  was  that  pro-
posed by  Segie,  modiﬁed  by  Doll.8 On  standardization  by  age
group and  gender,  it  was  considered  that  age  structures  are
the same  for  men  and  women.  Thus,  the  same  standard  pop-
ulation was  used  for  calculation  of  the  total  coefﬁcients  and
by gender.9
Regression  adjustments  were  performed.  The  adjusted
models were  semi-log  and  linear  deﬁned  as:
Semi-log:  In  Yt =  ˇ1 +  ˇ2t  +  εt
Linear:  Yt =  ˇ1 + ˇ2t  +  εt
In  which  the  dependent  variables  are  In  Yt and  Yt,
the independent  (or  regressor)  variable  is  time  t,  which
assumes values  1,2,3...  31.  ˇ1 represents  the  intercept,
ˇ2 angular  coefﬁcient,  and  εt represents  the  random  error.
This method  is  widely  used  and  recommended  by  the
IARC.10
In  the  linear  model,  the  angular  coefﬁcient  ˇ2 measures
absolute variation,  whereas  in  the  semi-logarithmic  model  it
measures the  proportional  variation  or  constant  relative  in
Y for  a  given  absolute  variation  in  the  value  of  the  regressor
(in this  case,  the  variable  t).
If  the  angular  coefﬁcient  is  positive,  Y  shows  an  increas-
ing trend;  if  it  is  negative,  Y  shows  a  decreasing  trend.
Angular coefﬁcients  with  p-value  <  5%  in  the  t-test  were
considered statistically  signiﬁcant.11
Regressions  were  generated:  for  the  total  in  each  age
group and  for  each  type  of  leukemia;  for  boys  and  girls  in
each age  group;  and  for  each  type  of  leukemia.  A  total  of
96 regressions  were  analyzed.
The  best  model  was  chosen  by  the  lower  value  criterion  of
the Akaike  Information  Criterion  (AIC)  and  the  lower  values
of Schwarz’s  Information  Criterion,  also  known  as  Bayesian
Information Criterion  (BIC).11 Signiﬁcances  of  the ̂ˇ2 model
were also  evaluated,  and  in  case  of  a  draw,  the  simplest
model was  chosen,  i.e.,  the  linear  one.
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Excel 2007  (Microsoft,  Washington,  USA)  and  Eviews  (IHS
lobal Inc.  Califórnia,  USA)  software  programs  were  used
or the  statistical  analysis.  The  level  of  signiﬁcance  was  set
t 5%.
The study  was  approved  by  the  Ethics  Committee  of  the
ealth Sciences  Center,  Universidade  Federal  do  Espírito
anto.
esults
he  population  of  deaths  from  leukemia  in  children  and
dolescents (0-19  years)  in  Brazil  consisted  of  30,029  cases
eported in  the  period  of  1980-2010.
Table  1  shows  the  results  of  the  best  models  for  each
ombination of  the  variables  gender,  age  range,  and  type  of
eukemia, including  the  total  data  for  both  genders  and  all
ypes of  leukemias.
An annual  percentage  rate  was  found  showing  a  4.24%
ecrease in  mortality  (for  ages  0-4  years)  when  evaluating
he leukemias  in  general,  without  establishing  subgroups  and
rrespective of  gender.
Mortality rates  from  lymphoid  leukemias  showed  an
ncreasing trend,  except  in  boys  aged  0-4  years,  which
howed an  annual  percentage  decrease  of  1.21%.
Mortality  rates  for  myeloid  leukemia  showed  an  increas-
ng trend,  and  the  most  accentuated  rate,  with  an  annual
ercentage of  1.77%  was  observed  in  the  age  group  0-4  years,
nalyzed in  both  genders  (Fig.  1).
Mortality  rates  for  the  subgroup  of  other  types  of
eukemias showed  a  decreasing  trend,  with  the  most  promi-
ent among  them  observed  for  females  in  the  age  group  5-9
ears, with  an  annual  percentage  decrease  of  4.16%  per  year.
iscussion
he  analysis  of  historical  trends  in  mortality  is  more  suit-
ble for  assessing  the  progress  of  cancer  than  the  incidence
rend. This  assertion  is  based  on  the  fact  that  vital  statistics,
uch as  mortality,  are  less  subject  to  changes  in  surveillance
nd cancer  recording  practices  than  registry  data  (e.g.,  data
or calculation  of  incidence).12
In  epidemiology,  studies  of  temporal  trends  may  be  use-
ul in  the  construction  of  the  phenomenon  etiology  or
alidation of  associations  between  risk  (mortality  and  inci-
ence) and  disease.  The  analysis  of  the  temporal  evolution
onstitutes a  tool  in  epidemiological  surveillance  for  primary
revention (reducing  exposure  to  risk  factors)  and  secondary
screening) of  diseases,  aiming  at  reducing  mortality.  In  pub-
ic health,  the  possible  changes  in  risks  from  the  past  lead  to
 wish  to  know  the  future  development,  aimed  to  plan  and
etermine budget  priorities  and  necessary  health  services.13
Few  investigations  have  studied  the  trend  of  leukemia  in
razilian children  and  adolescents.  In  a  study  conducted  in
ortaleza,14 there  was  a  decreasing  trend  in  mortality  from
eukemia. In  the  present  investigation,  the  same  pattern  was
ound for  an  overall  analysis  of  all  leukemias  in  both  genders.
However,  when  leukemia  was  analyzed  by  speciﬁc  sub-
roups, the  behavior  was  shown  to  be  different.  While
eukemias here  classiﬁed  as  ‘‘other  types’’  showed  a
ecrease in  mortality  in  all  age  groups  (Fig.  2),  the  lymphoid
eukemias showed  an  increasing  trend  in  the  age  group  15-19
590  Silva  FF  et  al.
Table  1  Results  of  regressions  of  the  chosen  models.
Variable  Gender  Age  range  Model  R2 p-Value  Trend  Growth  (%)
All  subgroups  of  leukemias  Male  0  to  4  Semi-log  -  0.375  No  trend  *
5  to  9  Linear  0.255  0.004  Increasing  0.70
10  to  14  Semi-log  -  0.000  Increasing  1.23
15  to  19  Semi-log  -  0.000  Increasing  1.40
Female 0  to  4  Semi-log  -  0.005  Increasing  1.09
5  to  9 Semi-log  -  0.521  No  trend  *
10  to  14 Semi-log  -  0.000 Increasing  1.28
15  to  19 Linear  0.584 0.000 Increasing  1.62
Both 0  to  4  Semi-log  -  0.000  Decreasing  -4.24
5  to  9  Linear  0.100  0.000  Decreasing  -0.72
10  to  14  Semi-log  -  0.603  No  trend  *
15  to  19  Semi-log  -  0.647  No  trend  *
Lymphoid  leukemias  Male  0  to  4  Linear  0.311  0.001  Decreasing  -1.21
5  to  9  Semi-log  -  0.194  No  trend  *
10  to  14  Linear  0.086  0.109  No  trend  *
15  to  19  Linear  0.291  0.002  Increasing  1.00
Female 0  to  4  Linear  0.058  0.194  No  trend  *
5  to  9  Linear  0.081  0.120  No  trend  *
10  to  14  Linear  0.076  0.133  No  trend  *
15  to  19  Linear  0.289  0.002  Increasing  1.21
Both 0  to  4  Semi-log  -  0.827  No  trend  *
5  to  9  Linear  0.100  0.084  No  trend  *
10  to  14  Linear  0.110  0.068  No  trend  *
15  to  19  Linear  0.455  0.000  Increasing  1.06
Myeloid  leukemias  Male  0  to  4  Linear  0.065  0.168  No  trend  *
5  to  9  Linear  0.200  0.012  Increasing  1.29
10  to  14  Linear  0.052  0.216  No  trend  *
15  to  19  Linear  0.000  0.965  No  trend  *
Female 0  to  4  Linear  0.288  0.002  Increasing  1.33
5  to  9  Linear  0.001  0.873  No  trend  *
10  to  14  Linear  0.111  0.067  No  trend  *
15  to  19 Linear  0.067  0.161  No  trend  *
Both 0  to  4 Linear  0.609  0.000  Increasing  1.77
5  to  9 Linear  0.151  0.031  Increasing  0.71
10  to  14 Linear  0.127  0.049  Increasing  0.53
15  to  19 Linear  0.031 0.346  No  trend  *
Other  types  of  leukemias Male  0  to  4 Linear  0.812  0.000  Decreasing  -4.14
5  to  9 Linear  0.662  0.000  Decreasing  -3.15
10  to  14  Linear  0.680  0.000  Decreasing  -2.83
15  to  19  Linear  0.518  0.000  Decreasing  -2.58
Female 0  to  4  Linear  0.799  0.000  Decreasing  -3.92
5  to  9  Linear  0.812  0.000  Decreasing  -4.16
10  to  14  Linear  0.494  0.000  Decreasing  -2.82
15  to  19  Linear  0.528  0.000  Decreasing  -2.60
Ambos 0  to  4  Linear  0.733  0.000  Decreasing  -3.16
5  to  9  Linear  0.843  0.000  Decreasing  -3.55
10  to  14  Linear  0.722  0.000  Decreasing  -2.84
15  to  19  Linear  0.658  0.000  Decreasing  -2.59
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iObs: Where there was no trend, the values were omitted and rep
Since the R2 values of semi-log and linear regressions are not com
ears  (Fig.  3).  When  considering  only  the  gender,  the  pattern
lso changed:  the  mortality  rates  from  leukemias  in  males
nd females  showed  an  increasing  trend.
Studies  performed  in  Latin  American  countries  (Brazil,
hile, and  the  Dominican  Republic)  showed  a  decrease  in
he mortality  trend.  This  behavior  can  be  explained  by  the
d
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d as *.
ble, only R2 values of the linear regressions werereported.
mprovement  in  cancer  diagnostic  techniques  and  increas-
ngly effective  chemotherapy  protocols,  procedures  that
irectly reﬂect  the  improved  disease  prognosis.15
The  present  study  showed  an  increasing  mortality  trend
t ages  15-19  years  for  lymphoid  leukemias,  for  both  gen-
ers. The  Latin-American  study15 discusses  this  difference
Childhood  leukemia  mortality  trends  in  Brazil  591
19
81
19
80
19
82
19
83
19
84
19
85
19
86
19
87
19
88
19
89
19
90
19
91
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
89
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
Both 0 to 4 Both 5 to 9 Both 10 to 14
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Figure  1  Line  chart  of  standardized  rates  of  mortality  from  myeloid  leukemia,  for  both  genders,  across  statistically  signiﬁcant
age  ranges  in  the  period  of  1980  to  2010,  in  Brazil.
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by  asserting  that  protocols  for  the  treatment  of  adolescents
and young  adults  are  not  adequate  for  this  age  group,  since
patients sometimes  are  treated  as  adults  and  sometimes  as
pediatric patients,  and  that  special  physical  and  psycho-
logical needs  for  this  age  group  are  not  recognized.  This
inappropriate treatment  is  demonstrated  as  differences  in
survival between  the  age  groups.  It  is  necessary  to  recog-
nize the  differences  in  the  biological  characteristics  of  the
disease, which  will  lead  to  further  advances  in  lymphoid
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Figure  3  Line  chart  of  standardized  rates  of  mortality  from  lymph
age  ranges  in  the  period  of  1980  to  2010,  in  Brazil.leukemias,  for  both  genders,  across  statistically  signiﬁcant  age
eukemia  therapeutic  protocols  for  older  children  (older
han 10  years).
The toxicity  and  mortality  associated  with  treatment
ave been  discussed  in  speciﬁc  studies  on  leukemia,  which
an inﬂuence  the  increased  rates  of  mortality  in  certain
roups.There have  been  reports  that  intensive  chemotherapy
n patients  with  acute  lymphoid  leukemia  leads  to  severe
eutropenia, exposing  patients  to  infections  that  can  cause
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eath  (41%  of  deaths  in  a  sample  were  related  to  sep-
ic shock).16 Estimates  have  described  that  deaths  related
o acute  lymphoid  leukemia  treatment  in  less  developed
ountries range  between  11%  and  20%;  for  acute  myeloid
eukemia, it  may  reach  33%.17
The  lack  of  information  about  data  quality  and  possible
igration of  cases,  as  well  as  the  heterogeneity  of  Brazilian
ates, are  limitations  of  the  study  and  need  to  be  consid-
red when  assessing  the  conclusions.  The  Brazilian  Mortality
nformation System  (Sistema  de  Informac¸ões  de  Mortalidade
 SIM)  was  created  in  1975  and  1976,  and  is  one  of  the  ﬁrst
n Brazil.  The  quality  of  mortality  data  has  improved  over
he years,  although  it  still  contains  ﬂaws.  It  is  estimated
hat the  coverage  of  mortality  data  in  1999  was  82%.  The
uality should  be  emphasized,  particularly  in  cases  of  death
rom cancer,  as  these  have  a  death  certiﬁcate  that  has  been
dequately completed.18
Thus,  the  mortality  rates  of  cancer  may  change  due  to
egistry artifacts  over  the  years.  It  is  possible  that  the  cases
hat were  once  classiﬁed  in  death  certiﬁcates  as  ‘‘other
eukemias’’ or  just  ‘‘leukemia’’  without  speciﬁcation,  have
igrated over  time  to  the  speciﬁc  cases,  causing  these  rates
o increase.  This  may  have  led  to  more  detailed  completion
f death  certiﬁcates.
As a  result,  there  was  a  more  pronounced  decreasing
ortality trend  in  cases  deﬁned  as  ‘‘other  leukemias’’  and
ncreased rates  of  speciﬁc  cases.  Another  aspect  to  be  con-
idered is  the  heterogeneity  regarding  the  regions.  While
razil generally  showed  a  decreasing  trend  in  the  estimated
ean annual  growth  rates  of  leukemia  mortality,  there  was
n increasing  trend  in  the  North  and  Northeast  regions.19
This  study  demonstrated  that  for  leukemias,  in  general,
here was  a  decreasing  trend  in  mortality  rates,  as  did
ther studies.19,20 However,  on  a  more  detailed  analysis,
hen assessing  subgroups  of  leukemias  and  specifying  gen-
er, these  trends  changed:  while  the  lymphoid  (except  for
he age  group  of  up  to  four  years  in  boys)  and  myeloid
eukemia rates  showed  an  increase,  the  subgroup  classi-
ed as  ‘‘other  leukemias’’  showed  a  decrease.  Observing  all
eukemias and  considering  gender,  mortality  rates  of  males
nd females  showed  an  increase.  A  detailed  analysis  by  sub-
roup of  leukemia,  age  range,  and  gender  showed  trends  not
bserved  in  other  studies,  thus  indicating  special  require-
ents for  the  analysis  of  each  variable.
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